Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients

被引:3
作者
Kaska, Milan [1 ,2 ,3 ]
Havel, Eduard [1 ,2 ,3 ]
Selke-Krulichova, Iva [2 ,3 ]
Safranek, Petr [1 ]
Bezouska, Jan [2 ,3 ]
Martinkova, Jirina [1 ]
机构
[1] Univ Hosp Hradec Kralove, Dept Surg, Sokolska 581, Hradec Kralove 50005, Czech Republic
[2] Charles Univ Prague, Fac Med Hradec Kralove, Acad Dept Surg, Sokolska 581, Hradec Kralove 50005, Czech Republic
[3] Univ Hosp, Dept Surg, Sokolska 581, Hradec Kralove 50005, Czech Republic
来源
BIOMEDICAL PAPERS-OLOMOUC | 2018年 / 162卷 / 03期
关键词
beta-lactam antibiotics; meropenem; piperacillin; pharmacokinetics/pharmacodynamics target; critically ill patient; AUGMENTED RENAL CLEARANCE; PHARMACOKINETIC EVALUATION; PIPERACILLIN-TAZOBACTAM; MEROPENEM; INFECTIONS; CREATININE; THERAPY; ATTAINMENT; SEPSIS; SERUM;
D O I
10.5507/bp.2018.011
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Aims. Critically ill patients undergoing aggressive fluid resuscitation and treated empirically with hydrosoluble time-dependent beta-lactam antibiotics are at risk for sub-therapeutic plasma concentrations. The aim of this study was to assess the impact of two covariates - creatinine clearance (Cl-cr) and cumulative fluid balance (CFB) on pharmacokinetics/pharmacodynamics (PK/PD) target attainment within a week of treatment with meropenem (ME) or piperacillin/tazobactam (PIP/TZB). Methods. In this prospective observational pharmacokinetic (PK) study, 18 critically ill patients admitted to a surgical Intensive Care Unit (ICU) were enrolled. The primary PK/PD target was free antibiotic concentrations above MIC at 100% of the dosing interval (100% fT > MIC) to obtain maximum bactericidal activity. Drug concentration was measured using liquid chromatography-tandem mass spectrometry. Results. The treatment of both 8 septic patients with IV extended ME dosing 2 g/3 h q8 h and 10 polytraumatized patients with IV intermittent PIP/TZB dosing 4.0/0.5 g q8 h was monitored. 8/18 patients (44%) manifested augmented renal clearence (ARC) where Cl-cr >= 130 mL/min/1.73 m(2). Maximum changes were reported on days 2-3: the median positive CFB followed by the large median volume of distribution: Vd(me) = 70.3 L (41.9-101.5), Vd(pip) = 46.8 L (39.7-60.0). 100%fT(me) > MIC was achieved in all patients on ME (aged >= 60 years), and only in two patients (non-ARC, aged >= 65 years) out of 10 on PIP/TZB. A mixed model analysis revealed positive relationship of CFBpip with Vd(pip) (P = 0.021). Conclusion. Assuming that the positive correlation between CFB and Vd exists for piperacillin in the setting of the pathological state, then CFB should predict Vd(pip) across subjects at each and every time point.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 35 条
[1]  
[Anonymous], 1977, CLIN INV BROCH
[2]   Meropenem - A review of its use in the treatment of serious bacterial infections [J].
Baldwin, Claudine M. ;
Lyseng-Williamson, Katherine A. ;
Keam, Susan J. .
DRUGS, 2008, 68 (06) :803-838
[3]   PHARMACOKINETICS OF MEROPENEM IN PATIENTS WITH INTRAABDOMINAL INFECTIONS [J].
BEDIKIAN, A ;
OKAMOTO, MP ;
NAKAHIRO, RK ;
FARINO, J ;
HESELTINE, PNR ;
APPLEMAN, MD ;
YELLIN, AE ;
BERNE, TV ;
GILL, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (01) :151-154
[4]   Pharmacokinetics of Meropenem in Critically Ill Patients With Severe Infections [J].
Binder, Lutz ;
Schwoerer, Harald ;
Hoppe, Sebastian ;
Streit, Frank ;
Neumann, Silke ;
Beckmann, Annett ;
Wachter, Rolf ;
Oellerich, Michael ;
Walson, Philip D. .
THERAPEUTIC DRUG MONITORING, 2013, 35 (01) :63-70
[5]   A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill Patients [J].
Carlier, Mieke ;
Roberts, Jason A. ;
Stove, Veronique ;
Verstraete, Alain G. ;
Lipman, Jeffrey ;
De Waele, Jan J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (08) :4689-4694
[6]   Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used? [J].
Carlier, Mieke ;
Carrette, Sofie ;
Roberts, Jason A. ;
Stove, Veronique ;
Verstraete, Alain ;
Hoste, Eric ;
Depuydt, Pieter ;
Decruyenaere, Johan ;
Lipman, Jeffrey ;
Wallis, Steven C. ;
De Waele, Jan J. .
CRITICAL CARE, 2013, 17 (03)
[7]   Can changes in renal function predict variations in β-lactam concentrations in septic patients? [J].
Casu, Giuseppe Stefano ;
Hites, Maya ;
Jacobs, Frederique ;
Cotton, Frederic ;
Wolff, Fleur ;
Beumier, Marjorie ;
De Backer, Daniel ;
Vincent, Jean-Louis ;
Taccone, Fabio Silvio .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (05) :422-428
[8]   Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy [J].
Claus, Barbara O. M. ;
Hoste, Eric A. ;
Colpaert, Kirsten ;
Robays, Hugo ;
Decruyenaere, Johan ;
De Waele, Jan J. .
JOURNAL OF CRITICAL CARE, 2013, 28 (05) :695-700
[9]   Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients [J].
De Waele, Jan J. ;
Lipman, J. ;
Akova, M. ;
Bassetti, M. ;
Dimopoulos, G. ;
Kaukonen, M. ;
Koulenti, D. ;
Martin, C. ;
Montravers, P. ;
Rello, J. ;
Rhodes, A. ;
Udy, A. A. ;
Starr, T. ;
Wallis, S. C. ;
Roberts, J. A. .
INTENSIVE CARE MEDICINE, 2014, 40 (09) :1340-1351
[10]   Right dose, right now: using big data to optimize antibiotic dosing in the critically ill [J].
Elbers, Paul ;
Girbes, Armand ;
Malbrain, Manu L. N. G. ;
Bosman, Rob .
ANAESTHESIOLOGY INTENSIVE THERAPY, 2015, 47 (05) :457-463